Author:
Tekade Rakesh K.,Tekade Muktika,Kumar Manoj,Chauhan Abhay S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference49 articles.
1. Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.
2. Drbohlavova J, Chomoucka J, Adam V, Ryvolova M, Eckschlager T, Hubalek J, et al. Nanocarriers for anticancer drugs–new trends in nanomedicine. Curr Drug Metab. 2013;14:547–64.
3. Dawidczyk CM, Kim C, Park JH, Russell LM, Lee KH, Pomper MG, et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release: Off J Control Release Soc. 2014;187C:133–44.
4. Bae S, Ma K, Kim TH, Lee ES, Oh KT, Park ES, et al. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. Biomaterials. 2012;33:1536–46.
5. Sethi A, Sher M, Akram MR, Karim S, Khiljee S, Sajjad A, et al. Albumin as a drug delivery and diagnostic tool and its market approved products. Acta Pol Pharm. 2013;70:597–600.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献